IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

API business of Dr. Reddy’s reports fall in sales

6:44 AM MST | February 11, 2014 | Deepti Ramesh

The pharmaceutical services and active ingredients (PSAI) business of Dr. Reddy’s Laboratories (Hyderabad, India) reports a 29% fall in sales in the company’s fiscal third quarter, ended 31 December 2013, compared with the year-ago quarter, to 5.06 billion Indian rupees ($81 million). Earnings figures for the PSAI business have not been disclosed. During the quarter, 19 drug master files (DMF) were filed globally, including 6 in Europe, Dr. Reddy’s says. As of 31 December 2013, the cumulative DMF filings were 612. Europe accounted for about...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa